Clinical Trial Update: Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pirfenidone for progressive chronic hypersensitivity pneumonitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Zagazig University | Conditions: Hypersensitivity Pneumonitis | Phase 2 | Status: COMPLETED